Michael E. Osband

1.1k total citations
42 papers, 868 citations indexed

About

Michael E. Osband is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Michael E. Osband has authored 42 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 16 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Michael E. Osband's work include CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Michael E. Osband is often cited by papers focused on CAR-T cell therapy research (11 papers), Immune Cell Function and Interaction (10 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Michael E. Osband collaborates with scholars based in United States, United Kingdom and Australia. Michael E. Osband's co-authors include Ronald P. McCaffrey, Philip T. Lavin, Robertson Parkman, Gordon F. Vawter, Jeffrey M. Lipton, Raphael Levey, Joel S. Greenberger, Ross E. Rocklin, Jay E. Gold and Dennis J. Beer and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Michael E. Osband

40 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Osband United States 16 378 321 249 146 121 42 868
MJ Cline United States 16 293 0.8× 240 0.7× 222 0.9× 68 0.5× 89 0.7× 36 1.2k
Leslie Garrison United States 11 212 0.6× 289 0.9× 107 0.4× 44 0.3× 46 0.4× 23 696
Yukiko Tsunematsu Japan 22 182 0.5× 256 0.8× 208 0.8× 220 1.5× 265 2.2× 61 1.2k
MG Roncarolo France 13 849 2.2× 84 0.3× 176 0.7× 80 0.5× 51 0.4× 20 1.2k
G. Bennett Humphrey United States 22 126 0.3× 100 0.3× 209 0.8× 110 0.8× 52 0.4× 68 1.2k
Valentina Querci Italy 13 1.6k 4.2× 218 0.7× 264 1.1× 99 0.7× 51 0.4× 13 1.9k
Wolfgang Emminger Austria 15 287 0.8× 85 0.3× 112 0.4× 41 0.3× 57 0.5× 39 816
P Resnitzky Israel 17 210 0.6× 218 0.7× 121 0.5× 54 0.4× 30 0.2× 61 974
Bruce A. Robbins United States 17 287 0.8× 70 0.2× 271 1.1× 43 0.3× 44 0.4× 26 963
E J Yunis United States 19 431 1.1× 131 0.4× 65 0.3× 79 0.5× 17 0.1× 43 897

Countries citing papers authored by Michael E. Osband

Since Specialization
Citations

This map shows the geographic impact of Michael E. Osband's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Osband with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Osband more than expected).

Fields of papers citing papers by Michael E. Osband

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Osband. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Osband. The network helps show where Michael E. Osband may publish in the future.

Co-authorship network of co-authors of Michael E. Osband

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Osband. A scholar is included among the top collaborators of Michael E. Osband based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Osband. Michael E. Osband is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gold, Jay E., Norman D. Bloom, Michail Shafir, et al.. (1995). Ex vivo activated memory t‐lymphocytes as adoptive cellular therapy of human soft‐tissue sarcoma targets with potentiation by Cis‐diamminedichloroplatinum (II). Journal of Surgical Oncology. 58(4). 212–221. 4 indexed citations
2.
Gold, Jay E., et al.. (1995). Adoptive transfer of ex vivo activated memory T-cells with or without cyclophosphamide for advanced metastatic melanoma: Results in 36 patients. European Journal of Cancer. 31(5). 698–708. 12 indexed citations
3.
4.
5.
Gold, Jay E., Ira J. Bleiweiss, Joel J. Bauer, et al.. (1994). Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis‐diamminedichloroplatinum(II). Journal of Surgical Oncology. 55(4). 222–228. 4 indexed citations
6.
Gold, Jay E., Michael E. Osband, & Robert J. Krane. (1994). Adoptive cellular therapy of urological neoplastic disease. Cancer Treatment Reviews. 20(2). 173–190. 2 indexed citations
7.
Gold, Jay E., et al.. (1993). Adoptive chemoimmunotherapy using Ex vivo activated memory T‐cells and cyclophosphamide: Tumor lysis syndrome of a metastatic soft tissue sarcoma. American Journal of Hematology. 44(1). 42–47. 29 indexed citations
8.
9.
Liu, et al.. (1993). Adoptive immunotherapy of hormone-refractory, stage D2 prostate cancer using ex vivo activated autologous T cells (autolymphocyte therapy): results from a pilot study.. PubMed. 4(3-4). 197–211. 4 indexed citations
10.
Levin, Myron J., et al.. (1991). The rapid diagnosis of infectious mononucleosis using an ELISA that detects IgM antibody to a peptide component of epstein-barr virus nuclear antigen. Diagnostic Microbiology and Infectious Disease. 14(4). 287–291. 5 indexed citations
11.
Osband, Michael E. & Susan D. Ross. (1990). Problems in the investigational study and clinical use of cancer immunotherapy. Immunology Today. 11(6). 193–195. 20 indexed citations
12.
Osband, Michael E., Philip T. Lavin, R. J. Krane, et al.. (1990). Effect of autolymphocyte therapy on survival and quality of life in patients with metastatic renal-cell carcinoma. The Lancet. 335(8696). 994–998. 92 indexed citations
13.
Osband, Michael E., et al.. (1989). Letterer-siwe disease in adults. Cancer. 63(1). 166–174. 24 indexed citations
14.
Osband, Michael E. & Robert J. Krane. (1988). Autolymphocyte Therapy: Previous Experience and Future Prospects. Pathology and Immunopathology Research. 7(6). 483–493. 4 indexed citations
15.
Osband, Michael E.. (1987). Histiocytosis X: Langerhans’ Cell Histiocytosis. Hematology/Oncology Clinics of North America. 1(4). 737–751. 50 indexed citations
16.
Osband, Michael E., Jeffrey M. Lipton, Philip T. Lavin, et al.. (1981). Histiocytosis-X. New England Journal of Medicine. 304(3). 146–153. 180 indexed citations
17.
Osband, Michael E., Philip T. Lavin, Anne Brown, Ronald P. McCaffrey, & Joel J. Alpert. (1981). 844 SUCCESSFUL TUMOR IMMUNOTHERAPY WITH CIMETIDINE BY AB-ROGATION OF SUPPRESSOR CELLS. Pediatric Research. 15. 583–583.
18.
Zilkah, S., Michael E. Osband, & Ronald P. McCaffrey. (1981). Characterization of the inhibitory effects of the phytotoxic agent propachlor (α-chloro-N-isopropyl-acetanilide), on L1210 cell proliferation. Cancer Letters. 13(3). 241–248. 3 indexed citations
19.
Osband, Michael E., et al.. (1972). Lead Paint Exposure in Migrant Labor Camps. PEDIATRICS. 49(4). 604–606. 2 indexed citations
20.
Osband, Michael E., et al.. (1972). Lead paint exposure in migrant labor camps.. PubMed. 49(4). 604–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by MJ Cline Breakdown of academic impact, for papers by Leslie Garrison Breakdown of academic impact, for papers by Yukiko Tsunematsu Breakdown of academic impact, for papers by MG Roncarolo Breakdown of academic impact, for papers by G. Bennett Humphrey Breakdown of academic impact, for papers by Valentina Querci Breakdown of academic impact, for papers by Wolfgang Emminger Breakdown of academic impact, for papers by P Resnitzky Breakdown of academic impact, for papers by Bruce A. Robbins Breakdown of academic impact, for papers by E J Yunis
Rankless by CCL
2026